1. TMB-8 inhibited respiration of rat thymocytes and rat liver mitochondria, probably by inhibition of NADH dehydrogenase. 2. TMB-8 markedly decreased both the cellular ATP concentration and the mitochondrial membrane potential in situ in thymocytes. 3. These effects occurred at, or well below, the concentrations used in other systems to investigate the role of intracellular calcium pools in signalling events. 4. We conclude that caution should be exercised in the interpretation of the effects of TMB-8.
1. TMB-8 inhibited respiration of rat thymocytes and rat liver mitochondria, probably by inhibition of NADH dehydrogenase. 2. TMB-8 markedly decreased both the cellular ATP concentration and the mitochondrial membrane potential in situ in thymocytes. 3. These effects occurred at, or well below, the concentrations used in other systems to investigate the role of intracellular calcium pools in signalling events. 4 . We conclude that caution should be exercised in the interpretation of the effects of TMB-8.
There is currently a great deal of interest in the identification and characterization of intracellular stores of calcium and their role in signal transmission and amplification. Inhibitors of the movement and action of calcium are therefore of considerable importance (reviewed by Rahwan, 1983) .
One such compound which has been increasingly used is the antiarrhythmic trimethoxybenzoate derivative, . Its exact mode of action on cells is not known; however, it is reported to be an 'intracellular calcium antagonist' and is thought to act by stabilizing intracellular membrane-bound calcium or inhibiting calcium transport across some non-mitochondrial subcellular membrane, perhaps the endoplasmic reticulum. The main evidence for this site of action is that TMB-8 blocks contraction in smooth and skeletal muscle in response to agents which cause release ofcalcium from intracellular stores, and inhibits caffeineinduced calcium release from isolated sarcoplasmic reticulum (Malagody & Chiou, 1974a,b; Chiou & Malagody, 1975) .
Since these early studies (Charo et al., 1976; Le Breton & Dinerstein, 1977; Gorman et al., 1979; Rittenhouse-Simmons & Deykin, 1978; Shaw & Lyons, 1982) , fibroblasts (Owen & Villereal, 1982; 1983; Mix et al., 1984) , adrenocortical cells (Rubin et al., 1980) , neutrophils (Smith & Iden, 1979; Smith et al., 1980; Smolen et al., 1981) , other polymorphonuclear leucocytes (Matsumoto et al., 1979; Juhl et al., 1982) and slime moulds (EuropeFinner & Newell, 1984) .
We have been investigating membrane potentials and intracellular calcium movements in lymphocytes before and after treatment with mitogens (Dippenaar & Brand, 1982; Felber & Brand, 1982a ,b, 1983a Baumgarten et al., 1983; Brand & Felber, 1984) . During this work we used TMB-8 to investigate the participation of nonmitochondrial calcium pools in the mitogenic response. It became clear that TMB-8 had severe side effects on thymocytes. It acted as a potent inhibitor of mitochondrial electron transport, and greatly lowered cellular ATP levels. The present paper reports these effects.
Experimental Rat thymocytes
These were prepared from 3-5-week-old Wistar rats. The thymus was removed, washed, and placed in culture medium (RPMI .1640 without Vol. 224 glutamine, containing 10mM-Hepes and brought to pH7.4 with NaOH). Cells were teased out, washed by centrifugation at 1000g for 5min, resuspended in culture medium at a density of (4-6) x 107 cells/ml and kept on ice until use. Viability was >95% by eosin exclusion; yield was (5-8) x 108 cells/thymus.
Rat liver mitochondria
These were prepared as described by Chappell & Hansford (1972) in 250mM-sucrose/1 mM-EGTA/ 5 mM-Tris/HCL, pH 7.2.
A TP assays Duplicate samples (250yu) from an incubation were added to 550Qul of 3% (w/v) HCl04 at 0-40C. After 10min they were neutralized with 300!s of 1OOmM-Mops (4-morpholinepropanesulphonic acid)/400mM-KOH at 0-4°C. Precipitated protein was sedimented by centrifugation and supernatants were assayed for ATP using a luciferinluciferase assay in a DuPont 760 Luminescence Biometer. ATP standards were subjected to a similar acidification and neutralization procedure.
Oxygen consumption
Rat thymocytes (5 x 107cells/ml) were suspended in RPMI 1640 culture medium at 37°C for 15min. A sample (2 ml) was transferred to a Clarktype oxygen electrode (Rank Bros., Bottisham, Cambridge, U.K.) maintained at 37°C containing 2ml of fresh medium. Rat liver mitochondria (0.23 mg of protein/ml) were suspended in 120 mMKCl/l mM-EGTA/3mM-Hepes, pH 7.0, at 30°C. Glutamate (8mM) plus malate (16mM) was added as substrate. Other additions are described in Fig.  1 Effect of TMB-8 on TPMP+ accumulation TPMP+ is a lipophilic cation that is accumulated by cells because of the potential differences across the plasma and mitochondrial membranes. Because of their greater membrane potential most of the accumulation is into the mitochondria. We have used TPMP+ to monitor the plasma membrane and mitochondrial membrane potentials in lymphocytes in situ (Felber & Brand, 1982a; Brand & Felber, 1984) . Fig. 2 shows that TMB-8 caused a considerable decrease in TPMP+ uptake by thymocytes, consistent with inhibition of mitochondrial electron transport and mitochondrial depolarization. The effect of rotenone, a well-characterized inhibitor of NADH dehydrogenase, was similar to that of TMB-8, but not as great. With either TMB-8 or rotenone present the residual TPMP+ accumulation was larger than that predicted for the plasma membrane alone, which, with a membrane potential of about 6OmV, should give about 10-fold accumulation of TPMP+ (Felber & Brand, 1982a) . Fig. 2 
Conclusions
The results we present here show that in rat thymocytes TMB-8 causes severe inhibition of electron flow, mitochondrial depolarization with possible calcium release, and a considerable fall in cellular ATP concentration. It has these effects at concentrations similar to, or well below, those used in other systems. Clearly great care in interpretation must be taken when using this inhibitor in thymocytes. Nonetheless, some of our results (S. M. Felber & M. D. Brand, unpublished work) are consistent with inhibition by TMB-8 of calcium release from intracellular stores, in addition to the effects on mitochondria that are reported here.
Most of the published reports of the action of TMB-8 on other cell types (see the introduction) make no mention of controls for secondary effects on the cells, and so should be treated with caution. In any case we suggest that future studies of intracellular calcium pools using TMB-8 in any system should be carried out sufficiently thoroughly to eliminate the possibility of side effects of this drug.
We thank Glyn Harper for technical assistance.
